ClinicalTrials.govpublic full text
Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer
graft versus host disease, leukemia, lymphoma, multiple myeloma and plasma cell neoplasm
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 172325
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.